Icon

OTREXUP PFS (nda204824)- (10MG/0.4ML (10MG/0.4ML),15MG/0.6ML (15MG/0.6ML),17.5MG/0.7ML (17.5MG/0.7ML),20MG/0.8ML (20MG/0.8ML),22.5MG/0.9ML (22.5MG/0.9ML),25MG/ML (25MG/ML))

METHOTREXATE OTTER PHARMS
10MG/0.4ML (10MG/0.4ML),15MG/0.6ML (15MG/0.6ML),17.5MG/0.7ML (17.5MG/0.7ML),20MG/0.8ML (20MG/0.8ML),22.5MG/0.9ML (22.5MG/0.9ML),25MG/ML (25MG/ML)
No Yes
Expired Expired
None None
None No
Otrexup PFS is a folate analog metabolic inhibitor indicated for the: • Management of patients with severe, active rheumatoid arthritis (RA) and polyarticular juvenile idiopathic arthritis (pJIA), who are intolerant of or had an inadequate response to first-line therapy. • Symptomatic control of severe, recalcitrant, disabling psoriasis in adults who are not adequately responsive to other forms of therapy.
0 0 0
Total Other Developers None
Drugs with Suitability No
10MG/0.4ML (10MG/0.4ML) ** ** - - -
15MG/0.6ML (15MG/0.6ML) ** ** - - -
17.5MG/0.7ML (17.5MG/0.7ML) ** ** - - -
20MG/0.8ML (20MG/0.8ML) ** ** - - -
22.5MG/0.9ML (22.5MG/0.9ML) ** ** - - -
25MG/ML (25MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

GenUs Advanced Search




Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.